Adaptive response to DNA-damaging agents: A review of potential mechanismsSTECCA, C; GERBER, G. B.Biochemical pharmacology. 1998, Vol 55, Num 7, pp 941-951, issn 0006-2952Article

Enzymic N-demethylation reaction catalysed by red blood cell cytosolSTECCA, C; CUMPS, J; DUVERGER-VAN BOGAERT, M et al.Biochemical pharmacology. 1992, Vol 43, Num 2, pp 207-211, issn 0006-2952Article

Detection of mutagenic activity in urine samples using a new concentration procedureDUVERGER-VAN BOGAERT, M; STECCA, C; LEONARD, A et al.Mutation research. 1987, Vol 178, Num 1, pp 21-24, issn 0027-5107Article

Regional and systemic prophylaxis with teicoplanin in monolateral and bilateral total knee replacemtn procedures : study of pharmacokinetics and tissue penetrationDE LALLA, F; NOVELLI, A; PELLIZZER, G et al.Antimicrobial agents and chemotherapy. 1993, Vol 37, Num 12, pp 2693-2698, issn 0066-4804Article

Oxidative activation of 2-aminofluorene by human red blood cell cytosolDUVERGER-VAN BOGAERT, M; WIAME, D; STECCA, C et al.Biochemical pharmacology. 1992, Vol 44, Num 12, pp 2422-2424, issn 0006-2952Article

Mutagenic activation of benzo[a]pyrene by human red blood cellsLO JACONO, F; STECCA, C; DUVERGER, M et al.Mutation research. 1992, Vol 268, Num 1, pp 21-26, issn 0027-5107Article

Subcellular fractionation and biochemical characterization of a purified erythrocyte suspensionSTECCA, C; DUVERGER-VAN BOGAERT, M.Chimica oggi. 1991, Vol 9, Num 7-8, pp 59-61, issn 0392-839XArticle

Mutagenicity of some heterocyclic amines in Salmonella typhimurium with metabolic activation by human red blood cell cytosolDUVERGER-VAN BOGAERT, M; CRUTZEN-FAYT, M.-C; STECCA, C et al.Mutation research. Genetic toxicology testing. 1991, Vol 261, Num 4, pp 261-265, issn 0165-1218Article

Postoperative infections following total knee replacement : An epidemiological studyLAZZARINI, L; PELLIZZER, G; STECCA, C et al.Journal of chemotherapy. 2001, Vol 13, Num 2, pp 182-187, issn 1120-009XArticle

Mutagenicity, carcinogenicity, and teratogenicity of acrylonitrileLEONARD, A; GERBER, G. B; STECCA, C et al.Mutation research. Reviews in mutation research. 1999, Vol 436, Num 3, pp 263-283, issn 1383-5742Article

Amphotericin B as primary therapy for cryptococcosis in patients with AIDS : reliability of relatively high doses administered over a relatively short periodDE LALLA, F; PELLIZZER, G; VAGLIA, A et al.Clinical infectious diseases. 1995, Vol 20, Num 2, pp 263-266, issn 1058-4838Article

HGV/GBV-C in liver tissue and in sera from patients with chronic hepatitis CFABRIS, P; BIASIN, M. R; DE LALLA, F et al.Infection. 1998, Vol 26, Num 5, pp 283-287, issn 0300-8126Article

Metabolic activation by a supernatant from human hepatoma cells : a possible alternative in mutagenic testsDUVERGER-VAN BOGAERT, M; DIERICKX, P. J; STECCA, C et al.Mutation research. Section on environmental mutagenesis and related subjects. 1993, Vol 292, Num 2, pp 199-204, issn 0165-1161Article

Activation of some aromatic amines to mutagenic products by human red blood cell cytosolDUVERGER-VAN BOGAERT, M; CRUTZEN-FAYT, M. C; STECCA, C et al.Mutation research. Mutation research letters. 1991, Vol 263, Num 4, pp 249-255, issn 0165-7992, 7 p.Article